First Republic Investment Management, Inc. Emergent Bio Solutions Inc. Transaction History

First Republic Investment Management, Inc.

$34.7 Billion
Q3 2023

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 16, 2022	SELL	$27.42 - $43.63 $23,965 - $38,132	-874 Reduced 6.91%	11,774 $365,000
Q1 2022 May 16, 2022	SELL	$36.48 - $52.22 $84,670 - $121,202	-2,321 Reduced 15.51%	12,648 $519,000
Q4 2021 Feb 09, 2022	SELL	$33.11 - $55.01 $1.43 Million - $2.38 Million	-43,335 Reduced 74.33%	14,969 $651,000
Q3 2021 Nov 12, 2021	SELL	$50.07 - $66.05 $43,360 - $57,199	-866 Reduced 1.46%	58,304 $2.92 Million
Q2 2021 Aug 16, 2021	SELL	$56.61 - $80.46 $54,119 - $76,919	-956 Reduced 1.59%	59,170 $3.73 Million
Q1 2021 May 14, 2021	BUY	$86.23 - $125.19 $217,730 - $316,104	2,525 Added 4.38%	60,126 $5.59 Million
Q4 2020 Feb 16, 2021	BUY	$79.17 - $111.47 $367,032 - $516,774	4,636 Added 8.75%	57,601 $5.16 Million
Q3 2020 Nov 12, 2020	BUY	$81.91 - $134.94 $63,725 - $104,983	778 Added 1.49%	52,965 $5.47 Million
Q2 2020 Aug 13, 2020	BUY	$54.33 - $89.52 $594,967 - $980,333	10,951 Added 26.56%	52,187 $4.13 Million
Q1 2020 May 13, 2020	BUY	$49.34 - $68.76 $1.36 Million - $1.89 Million	27,505 Added 200.31%	41,236 $2.39 Million
Q4 2019 Feb 14, 2020	SELL	$51.21 - $59.06 $116,912 - $134,833	-2,283 Reduced 14.26%	13,731 $741,000
Q3 2019 Nov 08, 2019	BUY	$40.6 - $57.2 $213,109 - $300,242	5,249 Added 48.76%	16,014 $837,000
Q2 2019 Aug 07, 2019	SELL	$39.92 - $53.86 $12,734 - $17,181	-319 Reduced 2.88%	10,765 $520,000
Q1 2019 Apr 30, 2019	SELL	$48.23 - $66.16 $65,785 - $90,242	-1,364 Reduced 10.96%	11,084 $560,000
Q4 2018 Feb 12, 2019	SELL	$55.63 - $73.24 $45,004 - $59,251	-809 Reduced 6.1%	12,448 $738,000
Q3 2018 Nov 13, 2018	BUY	$52.05 - $66.51 $65,426 - $83,603	1,257 Added 10.48%	13,257 $873,000
Q2 2018 Aug 14, 2018	BUY	$48.33 - $55.64 $124,498 - $143,328	2,576 Added 27.33%	12,000 $606,000
Q1 2018 May 10, 2018	BUY	$44.44 - $54.39 $16,620 - $20,341	374 Added 4.13%	9,424 $496,000
Q4 2017 Feb 09, 2018	SELL	$37.77 - $47.75 $334,755 - $423,208	-8,863 Closed	0 $0
Q3 2017 Nov 14, 2017	BUY	$34.14 - $40.45 $302,582 - $358,508	8,863	8,863 $359,000

Others Institutions Holding EBS

# of Institutions

159

Shares Held

33.7M

Call Options Held

453K

Put Options Held

931K

Black Rock Inc. New York, NY

3.84M
Shares

$36.4 Million
0.0% of portfolio
Vanguard Group Inc Valley Forge, PA

3.4M
Shares

$32.2 Million
0.0% of portfolio
Marshall Wace, LLP London, X0

2.49M
Shares

$23.6 Million
0.03% of portfolio
Charles Schwab Investment Management Inc San Francisco, CA

2.22M
Shares

$21.1 Million
0.0% of portfolio
State Street Corp Boston, MA

1.91M
Shares

$18.1 Million
0.0% of portfolio

View Full List

About Emergent BioSolutions Inc.

Ticker EBS
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 49,861,500
Market Cap $473M
Description
Emergent BioSolutions Inc., a life sciences company, focuses on the provision of preparedness and response solutions that address accidental, deliberate, and naturally occurring public health threats (PHTs) in the United States. The company's products address PHTs, which include chemical, biological, radiological, nuclear, and explosives; emergi...

More about EBS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of First Republic Investment Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on First Republic Investment Management, Inc. with notifications on news.

Account